These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 17287757)

  • 1. Relating protein pharmacology by ligand chemistry.
    Keiser MJ; Roth BL; Armbruster BN; Ernsberger P; Irwin JJ; Shoichet BK
    Nat Biotechnol; 2007 Feb; 25(2):197-206. PubMed ID: 17287757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-target networks derived from ligand set similarity.
    Keiser MJ; Hert J
    Methods Mol Biol; 2009; 575():195-205. PubMed ID: 19727616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain-based small molecule binding site annotation.
    Snyder KA; Feldman HJ; Dumontier M; Salama JJ; Hogue CW
    BMC Bioinformatics; 2006 Mar; 7():152. PubMed ID: 16545112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real spherical harmonic expansion coefficients as 3D shape descriptors for protein binding pocket and ligand comparisons.
    Morris RJ; Najmanovich RJ; Kahraman A; Thornton JM
    Bioinformatics; 2005 May; 21(10):2347-55. PubMed ID: 15728116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic annotation of protein function.
    Valencia A
    Curr Opin Struct Biol; 2005 Jun; 15(3):267-74. PubMed ID: 15922590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteases' prime targets revealed.
    Diamond SL; Greenbaum D
    Nat Biotechnol; 2008 Jun; 26(6):652-3. PubMed ID: 18536687
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-based maximal affinity model predicts small-molecule druggability.
    Cheng AC; Coleman RG; Smyth KT; Cao Q; Soulard P; Caffrey DR; Salzberg AC; Huang ES
    Nat Biotechnol; 2007 Jan; 25(1):71-5. PubMed ID: 17211405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding similarity network of ligand.
    Park K; Kim D
    Proteins; 2008 May; 71(2):960-71. PubMed ID: 18004762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network.
    Zhu M; Gao L; Li X; Liu Z; Xu C; Yan Y; Walker E; Jiang W; Su B; Chen X; Lin H
    J Drug Target; 2009 Aug; 17(7):524-32. PubMed ID: 19530902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of 3D atomic similarities and their use in the discrimination of small molecule protein-binding sites.
    Najmanovich R; Kurbatova N; Thornton J
    Bioinformatics; 2008 Aug; 24(16):i105-11. PubMed ID: 18689810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A searchable database for comparing protein-ligand binding sites for the analysis of structure-function relationships.
    Gold ND; Jackson RM
    J Chem Inf Model; 2006; 46(2):736-42. PubMed ID: 16563004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Poisson Index: a new probabilistic model for protein ligand binding site similarity.
    Davies JR; Jackson RM; Mardia KV; Taylor CC
    Bioinformatics; 2007 Nov; 23(22):3001-8. PubMed ID: 17893083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico carborane docking to proteins and potential drug targets.
    Calvaresi M; Zerbetto F
    J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemogenomics in drug discovery: computational methods based on the comparison of binding sites.
    Vulpetti A; Kalliokoski T; Milletti F
    Future Med Chem; 2012 Oct; 4(15):1971-9. PubMed ID: 23088277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding time for allosteric interactions.
    Wainer IW
    Nat Biotechnol; 2004 Nov; 22(11):1376-7. PubMed ID: 15529160
    [No Abstract]   [Full Text] [Related]  

  • 19. Method for comparing the structures of protein ligand-binding sites and application for predicting protein-drug interactions.
    Minai R; Matsuo Y; Onuki H; Hirota H
    Proteins; 2008 Jul; 72(1):367-81. PubMed ID: 18214952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening.
    Wang YS; Liu D; Wyss DF
    Magn Reson Chem; 2004 Jun; 42(6):485-9. PubMed ID: 15137040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.